I. Pabinger-Fasching

发表

Evaluation of a highly specific functional test for the detection of factor V Leiden

C. Mannhalter, W. Speiser, P. Quehenberger, 2000, International journal of clinical & laboratory research.

Evaluation of a new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant pathway.

B. Jilma, C. Mannhalter, W. Speiser, 1997, Thrombosis research.

Randomized double‐blind, placebo‐controlled trial of twice‐daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1

A. Gringeri, P. Mannucci, Y. Laurian, 1994 .

The course of anticardiolipin antibody levels under immunoadsorption therapy.

W. Hörl, K. Derfler, P. Quehenberger, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Thromboseprophylaxe in der muskuloskelettalen Chirurgie

S. Marlovits, J. Hochreiter, F. Rachbauer, 2014, Wiener klinische Wochenschrift.

Protein C Deficiency in Two Austrian Families

R. Bertina, H. Niessner, C. Korninger, 1983, Thrombosis and Haemostasis.

Symptomatic hereditary type-II protein C deficiency caused by a missense mutation in exon IX of the protein C gene (Gly381 to Ser)

H. Watzke, I. Pabinger-Fasching, E. Wittmann, 1994, Annals of Hematology.

Improved characteristics of aPC-resistance assay: Coatest aPC resistance by predilution of samples with factor V deficient plasma.

B. Jilma, C. Mannhalter, W. Speiser, 1996, American journal of clinical pathology.

Fibrinolytic therapy with rt-PA in a patient with paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome

U. Jäger, I. Pabinger-Fasching, A. Hauser, 2003, Annals of Hematology.

Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate.

I. Pabinger-Fasching, 2008, Thrombosis research.

Clinical and laboratory data in heterozygous factor V Leiden mutation positive versus negative patients with TIA and minor stroke.

P. Schnider, W. Lalouschek, S. Aull, 1995, Stroke.

Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia

W. Speiser, C. Korninger, K. Lechner, 1991, Annals of Hematology.

Protein C deficiency in Austria.

I. Pabinger-Fasching, E. Deutsch, 1985, Seminars in thrombosis and hemostasis.

Lupus Anticoagulants and Thrombosis

K. Lechner, I. Pabinger-Fasching, 1985 .

Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myeloma

E. Neumann, H. Niessner, K. Lechner, 1984, Blut.

Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients.

M. Morfini, E. Santagostino, C. Négrier, 2012, Blood.

Long-Term Safety and Efficacy of Recombinant Factor VIII FC (RFVIIIFC) in Adults and Adolescents With Severe Haemophilia A: An Interim Analysis of The ASPIRE Study

D. Perry, B. Konkle, J. Mahlangu, 2015 .

The story of a unique molecule in hemophilia A: recombinant single-chain factor VIII.

I. Pabinger-Fasching, 2016, Thrombosis research.

Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: Activation of blood coagulation, fibrinolysis and unspecific proteolysis

P. Kyrle, W. Speiser, K. Lechner, 1990, Blut.

Anticardiolipin antibodies in patients with venous thrombosis.

P. Kyrle, W. Speiser, K. Lechner, 1991, Haemostasis.

HLA-DR and Factor VIII Antibodies in Hemophilia A

W. Mayr, H. Niessner, K. Lechner, 1984, Thrombosis and Haemostasis.

677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke

C. Mannhalter, P. Schnider, W. Lalouschek, 1998, Journal of the Neurological Sciences.

Is there a possible role for haemostasis in the development of perigraft reaction complicating the modified Blalock Taussig shunt?

U. Salzer-Muhar, I. Pabinger-Fasching, S. Zacherl-Wightman, 2000, Cardiology in the Young.

High Levels of Plasma Protein C in Nephrotic Syndrome

H. Niessner, K. Lechner, E. Balzar, 1985, Thrombosis and Haemostasis.

Twelve novel and two recurrent mutations in 14 Austrian families with hereditary protein C deficiency

P. Reitsma, R. Bertina, C. Mannhalter, 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Relevance of a single dose of 270 μg/kg recombinant factor VIIa for the treatment of patients with haemophilia and inhibitors

J. Oldenburg, G. Auerswald, R. Zotz, 2009, Hämostaseologie.

Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim

M. Michel, A. Janssens, M. Sanz, 2011, Hematology.

Endogenous t‐PA‐antigen is an independent predictor of adverse cardiovascular events and all‐cause death in patients with atrial fibrillation

J. Wojta, M. Freynhofer, K. Huber, 2013, Journal of thrombosis and haemostasis : JTH.

High Risk of Acquired Immune Deficiency Syndrome (AIDS) and of AIDS Related Complex (ARC) in Hemophiliacs Seropositive for more than 5 Years

P. Kyrle, C. Korninger, K. Lechner, 1989, Thrombosis and Haemostasis.

Lymphocytes of haemophilia patients treated with clotting factor concentrates display activation-linked cell-surface antigens.

O. Majdic, W. Knapp, H. Stockinger, 1985, Clinical and Experimental Immunology.

Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature.

K. Lechner, I. Pabinger-Fasching, 1985, Haemostasis.

The relation between erythrocyte volume and folate levels is influenced by a common mutation in the methylenetetrahydrofolate reductase (MTHFR) gene (C677T).

L. Deecke, W. Serles, C. Mannhalter, 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control study.

L. Deecke, W. Serles, C. Mannhalter, 1999, Thrombosis research.

Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertension.

M. Trauner, M. Mandorfer, T. Reiberger, 2023, Thrombosis research.

A patient with sudden abdominal pain 10 years after successful renal transplantation.

J. Kettenbach, W. Hörl, P. Quehenberger, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Association of systemic inflammation with local tumour characteristics and survival in glioma patients

C. Marosi, G. Ricken, J. Hainfellner, 2019, Annals of Oncology.

Six Novel and Three Recurrent Mutations in Nine Austrian Patients with Hemophilia B

H. Watzke, I. Pabinger-Fasching, J. Walter, 1994, Thrombosis and Haemostasis.

Prevalence of COVID‐19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe

J. Astermark, C. Hermans, G. Dolan, 2023, Haemophilia : the official journal of the World Federation of Hemophilia.

HTLV-I Antibody Status in Hemophilia Patients Treated with Factor Concentrates Prepared from U.S. Plasma Sources and in Hemophilia Patients with AIDS

D. Lawrence, J. Jason, B. Evatt, 1985, Thrombosis and Haemostasis.

Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study Group.

P. Mannucci, A. Gringeri, Y. Laurian, 1994, British journal of haematology.